The two major types of IBD―Crohn’s disease and ulcerative colitis―present with overlapping but distinct symptoms. Crohn’s ...

In this Healio video, Edward L. Barnes, MD, MPH, associate professor of medicine, co-director of the Multidisciplinary IBD Center and associate fellowship program director at the University of North ...

Biocon Biologics secures multiple market access agreements in the US for its biosimilar, Yesintek, for treating Crohn's ...

This segment is sponsored by RGC Glass. The Crohn’s & Colitis Foundation is a non-profit, volunteer-driven organization ...

Biocon Biologics' Yesintek, a biosimilar to Stelara, has secured significant market access in the US, covering over 100 ...

New guidelines have been developed for the monitoring of patients with inflammatory bowel disease in an effort to prevent ...

DelveInsight’s “Ulcerative Colitis Market Insights, Epidemiology and Market Forecast – 2034” report delivers an in-depth ...

The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) ...

FOR more than a decade, former international high-fashion model and creator of Culinary Nerd TT Shalisha Stewart fought Crohn ...

Biocon Biologics' biosimilar Yesintek is approved for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis ...

Research shows that smoking may have beneficial effects on symptoms of ulcerative colitis. But the risks of starting this ...